执行功能障碍和认知衰退,这是帕金森病的非运动症状,在动物模型中捕捉到
Mahmoud M Iravani1, Mohammed Shoaib1
1Life and Medical Sciences, University of Hertfordshire.
International review of neurobiology
|February 10, 2024
概括
帕金森病 (PD) 认知功能障碍影响生活质量. 本综述研究了PD认知缺陷的动物模型和药理疗法,强调了需要系统的临床前方法.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非运动症状,特别是认知功能障碍,显著影响帕金森病 (PD) 患者的生活质量.
- 认知功能障碍在PD是一个不断增长的研究领域,临床方面详细介绍在本卷的其他地方.
- 了解PD相关认知障碍的神经生物学对于开发有效治疗方法至关重要.
研究的目的:
- 审查用于研究帕金森病认知功能障碍的转化动物模型.
- 探索各种动物模型的实用性,从动物到非人类灵长类动物,研究PD认知.
- 评估旨在恢复PD模型中的认知缺陷的药理干预措施的现状.
主要方法:
- 对帕金森病转化动物模型的文献综述.
- 分析使用动物和非人类灵长类动物的研究,以建模与PD相关的认知功能障碍.
- 检查在临床前PD研究中针对认知缺陷的药理学方法.
主要成果:
- 已经利用各种动物模型来研究帕金森病的认知功能障碍.
- 药理学研究表明恢复认知缺陷的潜力,但结果各不相同.
- 在临床前研究中,发现缺乏针对认知功能障碍等非运动症状的系统方法.
结论:
- 翻译性动物模型是研究帕金森病认知功能障碍的神经生物学的宝贵工具.
- 目前的药理学策略有希望,但需要更系统的调查和验证.
- 需要标准化的临床前方法来有效地解决认知障碍作为PD的非运动症状.
相关概念视频
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484


